Literature DB >> 20614491

Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity.

Jun Zhou1, De-Wu Zhong, Qun-Wei Wang, Xiong-Ying Miao, Xun-Di Xu.   

Abstract

AIM: To investigated if paclitaxel can attenuate hepatic fibrosis in rat hepatic stellate cells (RHSCs).
METHODS: RHSCs were cultured in vitro and randomly assigned to four groups: normal control group (treated only with Dulbecco's Modified Eagle's Medium), Taxol group (200 nmol/L paclitaxel was added to the cell culture), transforming growth factor (TGF)-beta group (5 ng/mL recombinant human TGF-beta1 was added to the cell culture), and TGF-beta + Taxol group. TGF-beta signaling cascade and status of various extracellular matrix proteins were evaluated by real time reverse transcriptase polymerase chain reaction and Western blotting.
RESULTS: The paclitaxel treatment markedly suppressed Smad2/3 phosphorylation. This was associated with attenuated expression of collagen I and III and fibronectin in RHSCs.
CONCLUSION: These data indicate that 200 nmol/L paclitaxel ameliorates hepatic fibrosis via modulating TGF-beta signaling, and that paclitaxel may have some therapeutic value in humans with hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20614491      PMCID: PMC2900727          DOI: 10.3748/wjg.v16.i26.3330

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.

Authors:  Shoukang Zhu; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

Review 2.  The taxoids: paclitaxel and docetaxel.

Authors:  K Gelmon
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

3.  Promotion of microtubule assembly in vitro by taxol.

Authors:  P B Schiff; J Fant; S B Horwitz
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

4.  Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury.

Authors:  Yoshiya Tahashi; Koichi Matsuzaki; Masataka Date; Katsunori Yoshida; Fukiko Furukawa; Yasushi Sugano; Masanori Matsushita; Yasuo Himeno; Yutaka Inagaki; Kyoichi Inoue
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

5.  Microtubule binding to Smads may regulate TGF beta activity.

Authors:  C Dong; Z Li; R Alvarez; X H Feng; P J Goldschmidt-Clermont
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

Review 6.  Roles of TGF-beta in hepatic fibrosis.

Authors:  Axel M Gressner; Ralf Weiskirchen; Katja Breitkopf; Steven Dooley
Journal:  Front Biosci       Date:  2002-04-01

7.  Activation of p34cdc2 coincident with taxol-induced apoptosis.

Authors:  K L Donaldson; G L Goolsby; P A Kiener; A F Wahl
Journal:  Cell Growth Differ       Date:  1994-10

8.  Regression of collagen-induced arthritis with taxol, a microtubule stabilizer.

Authors:  E Brahn; C Tang; M L Banquerigo
Journal:  Arthritis Rheum       Date:  1994-06

Review 9.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

10.  Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis.

Authors:  Xiao-Ling Wu; Wei-Zheng Zeng; Ming-De Jiang; Jian-Ping Qin; Hui Xu
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

View more
  22 in total

1.  A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancer.

Authors:  Hidehiro Tajima; Isamu Makino; Ryosuke Gabata; Mitsuyoshi Okazaki; Yoshinao Ohbatake; Hiroyuki Shimbashi; Shinich Nakanuma; Hiroto Saitoh; Mari Shimada; Takahisa Yamaguchi; Koichi Okamoto; Hideki Moriyama; Jun Kinoshita; Keishi Nakamura; Tomoharu Miyashita; Itasu Ninomiya; Sachio Fushida; Hiroko Ikeda; Tetsuo Ohta
Journal:  Mol Clin Oncol       Date:  2020-12-14

2.  Paclitaxel-eluting balloon dilation of biliary anastomotic stricture after liver transplantation.

Authors:  Anna Hüsing; Holger Reinecke; Vito R Cicinnati; Susanne Beckebaum; Christian Wilms; Hartmut H Schmidt; Iyad Kabar
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  cGMP inhibits TGF-beta signaling by sequestering Smad3 with cytosolic beta2-tubulin in pulmonary artery smooth muscle cells.

Authors:  Kaizheng Gong; Dongqi Xing; Peng Li; Robert H Hilgers; Fadi G Hage; Suzanne Oparil; Yiu-Fai Chen
Journal:  Mol Endocrinol       Date:  2011-08-25

4.  Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.

Authors:  Hidehiro Tajima; Isamu Makino; Yoshinao Ohbatake; Shinichi Nakanuma; Hironori Hayashi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hiroyuki Takamura; Tetsuo Ohta
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

5.  Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signalling.

Authors:  Lin Song; Tian-Yu Chen; Xiao-Juan Zhao; Qiang Xu; Rui-Qing Jiao; Jian-Mei Li; Ling-Dong Kong
Journal:  Br J Pharmacol       Date:  2019-04-24       Impact factor: 8.739

6.  Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hiroyuki Shinbashi; Atsushi Hirose; Mitsuyoshi Okazaki; Takahisa Yamaguchi; Yoshinao Ohbatake; Koichi Okamoto; Shinichi Nakanuma; Seisho Sakai; Jun Kinoshita; Isamu Makino; Keishi Nakamura; Hironori Hayashi; Katsunobu Oyama; Masafumi Inokuchi; Tomoharu Miyashita; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Hiroyuki Nakamura
Journal:  Mol Clin Oncol       Date:  2017-03-30

7.  Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hiroyuki Shinbashi; Atsushi Hirose; Tomoya Tsukada; Koichi Okamoto; Shinichi Nakanuma; Seisho Sakai; Hiroyuki Furukawa; Isamu Makino; Keishi Nakamura; Hironori Hayashi; Katsunobu Oyama; Masafumi Inokuchi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hideto Fujita; Hiroyuki Takamura; Itasu Ninomiya; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Hisatsugu Mouri; Koushiro Ohtsubo
Journal:  Oncol Lett       Date:  2012-09-12       Impact factor: 2.967

8.  [Effect of low-concentration paclitaxel on collagen deposition outside rat pulmonary artery smooth muscle cells and related mechanism].

Authors:  Yan Luo; Liang Xie; Han-Min Liu; Bin Liu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-09

9.  Low-dose paclitaxel ameliorates fibrosis in the remnant kidney model by down-regulating miR-192.

Authors:  Lin Sun; Dongshan Zhang; Fuyou Liu; Xudong Xiang; Guanghui Ling; Li Xiao; Yinghong Liu; Xuejing Zhu; Ming Zhan; Yeyi Yang; Vinay K Kondeti; Yashpal S Kanwar
Journal:  J Pathol       Date:  2011-08-24       Impact factor: 7.996

10.  Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats.

Authors:  Zeinab A El-Gendy; Salma A El-Marasy; Rania F Ahmed; Seham A El-Batran; Sahar S Abd El-Rahman; A Ramadan; S A H Youssef
Journal:  Heliyon       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.